Neurology News

March is Multiple Sclerosis Awareness Month, a time to improve knowledge of and highlight the growing treatment options for progressive types of this degenerative disease.

The FDA approved Ultomiris for the treatment of adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, according to a press release from Alexion.

IGC Pharma has announced positive interim results from an ongoing phase 2 trial investigating IGC-AD1, a natural THC-based oral formulation, as a treatment for agitation in dementia from Alzheimer’s disease.

Nontraditional risk factors such as migraine, valvular heart disease and thrombophilia may be linked to increased risk for stroke among younger adults, researchers reported.

WEST PALM BEACH, Fla. — Obesity was strongly associated with disability worsening, disease progression and declining quality of life in a cohort of adults diagnosed with multiple sclerosis, according to a presenter at ACTRIMS 2024.

In our last post, we saw how rollover equity fits into the overall consideration paid to a selling physician owner of a physician practice.

NEW YORK — Patients with moderate to severe headache experienced a clinically significant reduction in headache symptoms after wearing Neurolens contoured prism technology, a company executive said at Vision Expo East.

A Boston-area developer of brain-computer interface technology and a Canadian biotech firm have announced a collaboration to globally commercialize the former’s brain health tools.

In a prospective cohort study, excessive exposure to outdoor artificial light at night and air pollution were associated with elevated risk for stroke, researchers reported in Stroke.

WEST PALM BEACH, Fla. — Inclusion of underrepresented racial and ethnic groups, along with older patients, patients from rural areas and uninsured patients in multiple sclerosis-targeted clinical trials is likely to improve outcomes, according to a speaker.